Trending
Covaxin Phase 3 Trials Show 77.8% Efficacy Against COVID-19
The Made-In-India vaccine manufacturer, Bharat Biotech, may have to face a delay in getting approval from the Indian drug regulator for Covaxin. According to Economic Times, the vaccine manufacturer might get the requisite approval till next year since the phase three trial has not been...